Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II frontline CRd induction, transplant, consolidation, and lenalidomide maintenance in newly diagnosed multiple myeloma
2012-005804-16Phase 2Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Apr 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carfilzomib, lenalidomide, dexamethasone in multiple myeloma (MM), sponsored by Centre hospitalier universitaire de Toulouse. Started Apr 2013; status: completed.
02
Drugs
carfilzomiblenalidomidedexamethasone
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2012-005804-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005804-16.